The p53 tumour suppressor is frequently mutated in human cancer cells.14 If not affected directly by gene mutation, frequent deregulation of the p53 activating/inactivating pathway is observed such as overexpression of its negative regulatory E3 ubiquitin ligase Mdm2. The gene discussed is TP53; the disease is neoplasm.